Blinding in Randomized Clinical Trials: Imposed Impartiality
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Blinding, or "masking," is a crucial method for reducing bias in randomized clinical trials. In this paper, we review important methodological aspects of blinding, emphasizing terminology, reporting, bias mechanisms, empirical evidence, and the risk of unblinding. Theoretical considerations and empirical analyses support the blinding of patients, health-care providers, and outcome assessors as to the trial intervention to which patients have been allocated. We encourage extensive pretrial testing of blinding procedures and explicit reporting of who was in the blinded condition and the methods used to ensure blinding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Self-citationBlinding in randomised trials: hiding who got what
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07816-9 · Cited by 952
Placebo interventions for all clinical conditions
Hróbjartsson, A., & Gøtzsche, P. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003974.pub3 · Cited by 777
Self-citationReporting methods of blinding in randomized trials assessing nonpharmacological treatments
Boutron, I., Guittet, L., Estellat, C., Moher, D., Hróbjartsson, A., & Ravaud, P. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040061 · Cited by 389
Self-citationDevereaux, P. J. (2001) · JAMA · doi:10.1001/jama.285.15.2000 · Cited by 258
Devereaux, P. J., Choi, P. T.-L., El-Dika, S., Bhandari, M., Montori, V. M., Schünemann, H. J., Garg, A. X., Busse, J. W., Heels-Ansdell, D., Ghali, W. A., et al. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.03.017 · Cited by 209
Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't?
Sackett, D. L. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym088 · Cited by 150
Towards a proposal for assessment of blinding success in clinical trials: up-to-date review
Kolahi, J., Bang, H., & Park, J. (2009) · Community Dentistry and Oral Epidemiology · doi:10.1111/j.1600-0528.2009.00494.x · Cited by 137
Cited by
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
The placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
Hróbjartsson, A., Emanuelsson, F., Skou Thomsen, A. S., Hilden, J., & Brorson, S. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu115 · Cited by 462
Self-citationCONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081124 · Cited by 205
Self-citationSPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials
Hróbjartsson, A., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081660 · Cited by 171
Self-citationJuul, S., Gluud, C., Simonsen, S., Frandsen, F. W., Kirsch, I., & Jakobsen, J. C. (2021) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111407 · Cited by 135
Promoting public access to clinical trial protocols: challenges and recommendations
Chan, A.-W., & Hróbjartsson, A. (2018) · Trials · doi:10.1186/s13063-018-2510-1 · Cited by 84
Self-citationBello, S., Moustgaard, H., & Hróbjartsson, A. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.08.002 · Cited by 33
Self-citationVictorson, D. E., Sauer, C. M., Wolters, L., Maletich, C., Lukoff, K., & Sufrin, N. (2020) · Mindfulness · doi:10.1007/s12671-020-01373-y · Cited by 33
“Recognizing that assessment of blinding success is rarely reported and methodologically controversial (Hróbjartsson and Boutron 2011), criteria were considered to be adequately met if articles described procedures that would likely result in successful blinding.”
Background
Metadata
- Authors
- Hróbjartsson, A., & Boutron, I.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2011-10-12
- Volume
- 90
- Issue
- 5
- Pages
- 732-736
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1998125334
- Cited by
- 95
- References
- 13
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.